CompaniesBRI Biopharmaceutical Research

BRI Biopharmaceutical Research

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

0

As Collaborator

3

Total Enrollment

46

By Phase

PHASE2: 3

By Status

RECRUITING: 2WITHDRAWN: 1

Recent Trials

NCT06647524Collaborator
Pilot fMRI Studies of Aging-Related Effects of THC
PHASE2Recruiting
10 participants
Started: Jul 1, 2025 · Completed: Dec 31, 2027
NCT06523725Collaborator
Trial Investigating the Safety and Efficacy of BRC-003 in Refractory Post-Traumatic Epilepsy
PHASE2Withdrawn
Started: Nov 1, 2024 · Completed: Apr 15, 2025
NCT06538389Collaborator
High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer
PHASE2Recruiting
36 participants
Started: Aug 26, 2024 · Completed: Aug 15, 2026
Related Companies
Frontage
acquired